Brief: Adial Pharmaceuticals Provides Business Update And Reports First Quarter 2022 Financial Results

Azora Therapeutics

16/05/2022 14:30

Adial Pharmaceuticals Inc  ADIL.O :
    * ADIAL PHARMACEUTICALS PROVIDES BUSINESS UPDATE AND REPORTS
FIRST
QUARTER 2022 FINANCIAL RESULTS
    * Q1 LOSS PER SHARE $0.13
    * ENDED Q1 WITH CASH AND CASH EQUIVALENTS OF $12.7 MILLION

Source text for Eikon:  ID:nGNX3FTLJp 
Further company coverage:  ADIL.O